171 related articles for article (PubMed ID: 21930971)
1. Complement regulation at necrotic cell lesions is impaired by the age-related macular degeneration-associated factor-H His402 risk variant.
Lauer N; Mihlan M; Hartmann A; Schlötzer-Schrehardt U; Keilhauer C; Scholl HP; Charbel Issa P; Holz F; Weber BH; Skerka C; Zipfel PF
J Immunol; 2011 Oct; 187(8):4374-83. PubMed ID: 21930971
[TBL] [Abstract][Full Text] [Related]
2. Monomeric CRP contributes to complement control in fluid phase and on cellular surfaces and increases phagocytosis by recruiting factor H.
Mihlan M; Stippa S; Józsi M; Zipfel PF
Cell Death Differ; 2009 Dec; 16(12):1630-40. PubMed ID: 19680263
[TBL] [Abstract][Full Text] [Related]
3. Defective complement control of factor H (Y402H) and FHL-1 in age-related macular degeneration.
Skerka C; Lauer N; Weinberger AA; Keilhauer CN; Sühnel J; Smith R; Schlötzer-Schrehardt U; Fritsche L; Heinen S; Hartmann A; Weber BH; Zipfel PF
Mol Immunol; 2007 Jul; 44(13):3398-406. PubMed ID: 17399790
[TBL] [Abstract][Full Text] [Related]
4. An imbalance of human complement regulatory proteins CFHR1, CFHR3 and factor H influences risk for age-related macular degeneration (AMD).
Fritsche LG; Lauer N; Hartmann A; Stippa S; Keilhauer CN; Oppermann M; Pandey MK; Köhl J; Zipfel PF; Weber BH; Skerka C
Hum Mol Genet; 2010 Dec; 19(23):4694-704. PubMed ID: 20843825
[TBL] [Abstract][Full Text] [Related]
5. Complement factor H binding of monomeric C-reactive protein downregulates proinflammatory activity and is impaired with at risk polymorphic CFH variants.
Molins B; Fuentes-Prior P; Adán A; Antón R; Arostegui JI; Yagüe J; Dick AD
Sci Rep; 2016 Mar; 6():22889. PubMed ID: 26961257
[TBL] [Abstract][Full Text] [Related]
6. The effect of photo-oxidative stress and inflammatory cytokine on complement factor H expression in retinal pigment epithelial cells.
Lau LI; Chiou SH; Liu CJ; Yen MY; Wei YH
Invest Ophthalmol Vis Sci; 2011 Aug; 52(9):6832-41. PubMed ID: 21743006
[TBL] [Abstract][Full Text] [Related]
7. Functional and structural implications of the complement factor H Y402H polymorphism associated with age-related macular degeneration.
Ormsby RJ; Ranganathan S; Tong JC; Griggs KM; Dimasi DP; Hewitt AW; Burdon KP; Craig JE; Hoh J; Gordon DL
Invest Ophthalmol Vis Sci; 2008 May; 49(5):1763-70. PubMed ID: 18263814
[TBL] [Abstract][Full Text] [Related]
8. Monomeric C-reactive protein modulates classic complement activation on necrotic cells.
Mihlan M; Blom AM; Kupreishvili K; Lauer N; Stelzner K; Bergström F; Niessen HW; Zipfel PF
FASEB J; 2011 Dec; 25(12):4198-210. PubMed ID: 21856781
[TBL] [Abstract][Full Text] [Related]
9. LOC387715/HTRA1 and complement factor H variants in patients with age-related macular degeneration seen at the mayo clinic.
Pulido JS; Peterson LM; Mutapcic L; Bryant S; Highsmith WE
Ophthalmic Genet; 2007 Dec; 28(4):203-7. PubMed ID: 18161619
[TBL] [Abstract][Full Text] [Related]
10. The factor H variant associated with age-related macular degeneration (His-384) and the non-disease-associated form bind differentially to C-reactive protein, fibromodulin, DNA, and necrotic cells.
Sjöberg AP; Trouw LA; Clark SJ; Sjölander J; Heinegård D; Sim RB; Day AJ; Blom AM
J Biol Chem; 2007 Apr; 282(15):10894-900. PubMed ID: 17293598
[TBL] [Abstract][Full Text] [Related]
11. Interference of antimodified C-reactive protein autoantibodies from lupus nephritis in the biofunctions of modified C-reactive protein.
Yang XW; Tan Y; Yu F; Zhao MH
Hum Immunol; 2012 Feb; 73(2):156-63. PubMed ID: 22192784
[TBL] [Abstract][Full Text] [Related]
12. Y402H polymorphism of complement factor H affects binding affinity to C-reactive protein.
Laine M; Jarva H; Seitsonen S; Haapasalo K; Lehtinen MJ; Lindeman N; Anderson DH; Johnson PT; Järvelä I; Jokiranta TS; Hageman GS; Immonen I; Meri S
J Immunol; 2007 Mar; 178(6):3831-6. PubMed ID: 17339482
[TBL] [Abstract][Full Text] [Related]
13. Structure shows that a glycosaminoglycan and protein recognition site in factor H is perturbed by age-related macular degeneration-linked single nucleotide polymorphism.
Herbert AP; Deakin JA; Schmidt CQ; Blaum BS; Egan C; Ferreira VP; Pangburn MK; Lyon M; Uhrín D; Barlow PN
J Biol Chem; 2007 Jun; 282(26):18960-8. PubMed ID: 17360715
[TBL] [Abstract][Full Text] [Related]
14. Genetic deficiency of complement factor H in a patient with age-related macular degeneration and membranoproliferative glomerulonephritis.
Montes T; Goicoechea de Jorge E; Ramos R; Gomà M; Pujol O; Sánchez-Corral P; Rodríguez de Córdoba S
Mol Immunol; 2008 May; 45(10):2897-904. PubMed ID: 18336910
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the Y402H variant of the complement factor H gene in age-related macular degeneration.
Baird PN; Islam FM; Richardson AJ; Cain M; Hunt N; Guymer R
Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4194-8. PubMed ID: 17003406
[TBL] [Abstract][Full Text] [Related]
16. Effect of modified C-reactive protein on complement activation: a possible complement regulatory role of modified or monomeric C-reactive protein in atherosclerotic lesions.
Ji SR; Wu Y; Potempa LA; Liang YH; Zhao J
Arterioscler Thromb Vasc Biol; 2006 Apr; 26(4):935-41. PubMed ID: 16456095
[TBL] [Abstract][Full Text] [Related]
17. Genetics. A clearer view of macular degeneration.
Marx J
Science; 2006 Mar; 311(5768):1704-5. PubMed ID: 16556817
[No Abstract] [Full Text] [Related]
18. Transgenic mice expressing variants of complement factor H develop AMD-like retinal findings.
Ufret-Vincenty RL; Aredo B; Liu X; McMahon A; Chen PW; Sun H; Niederkorn JY; Kedzierski W
Invest Ophthalmol Vis Sci; 2010 Nov; 51(11):5878-87. PubMed ID: 20538999
[TBL] [Abstract][Full Text] [Related]
19. Two genetic pathways for age-related macular degeneration.
DeWan A; Bracken MB; Hoh J
Curr Opin Genet Dev; 2007 Jun; 17(3):228-33. PubMed ID: 17467263
[TBL] [Abstract][Full Text] [Related]
20. Association of complement factor H Y402H polymorphism with phenotype of neovascular age related macular degeneration in Israel.
Chowers I; Cohen Y; Goldenberg-Cohen N; Vicuna-Kojchen J; Lichtinger A; Weinstein O; Pollack A; Axer-Siegel R; Hemo I; Averbukh E; Banin E; Meir T; Lederman M
Mol Vis; 2008; 14():1829-34. PubMed ID: 18852870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
